BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986;10:1271-7. [PMID: 3817762 DOI: 10.1111/j.1365-2559.1986.tb02570.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Kamada T, Maruyama Y, Monobe Y, Haruma K. Endoscopic features and clinical importance of autoimmune gastritis. Dig Endosc 2022;34:700-13. [PMID: 34674318 DOI: 10.1111/den.14175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
2 Vaiphei K. Precancerous Lesions: Atrophic Gastritis, Intestinal Metaplasia, Natural Course of Chronic Gastritis and Associated Risk Factors. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
4 Liu W, Pan HF, Wang Q, Zhao ZM. The application of transgenic and gene knockout mice in the study of gastric precancerous lesions. Pathol Res Pract 2018;214:1929-39. [PMID: 30477641 DOI: 10.1016/j.prp.2018.10.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
5 Fang JY, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, Lv NH, Chen YX, Lv B; Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on chronic gastritis (2017, Shanghai). J Dig Dis 2018;19:182-203. [PMID: 29573173 DOI: 10.1111/1751-2980.12593] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
6 Burkitt MD, Duckworth CA, Williams JM, Pritchard DM. Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Dis Model Mech 2017;10:89-104. [PMID: 28151409 DOI: 10.1242/dmm.027649] [Cited by in Crossref: 56] [Cited by in F6Publishing: 88] [Article Influence: 9.3] [Reference Citation Analysis]
7 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 151] [Cited by in F6Publishing: 160] [Article Influence: 16.8] [Reference Citation Analysis]
8 González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032. [PMID: 23280711 DOI: 10.1002/ijc.28003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
9 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal. World J Gastroenterol 2012; 18(12): 1279-1285 [PMID: 22493541 DOI: 10.3748/wjg.v18.i12.1279] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
11 Greaves P. Digestive System. Histopathology of Preclinical Toxicity Studies. Elsevier; 2012. pp. 325-431. [DOI: 10.1016/b978-0-444-53856-7.00008-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
12 Goldenring JR, Nam KT. Oxyntic atrophy, metaplasia, and gastric cancer. Prog Mol Biol Transl Sci. 2010;96:117-131. [PMID: 21075342 DOI: 10.1016/b978-0-12-381280-3.00005-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
13 Wang L, Zhang XY, Xu L, Liu WJ, Zhang J, Zhang JP. Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncol Lett 2011;2:707-12. [PMID: 22848253 DOI: 10.3892/ol.2011.292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 González CA, Pardo ML, Liso JM, Alonso P, Bonet C, Garcia RM, Sala N, Capella G, Sanz-Anquela JM. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int J Cancer. 2010;127:2654-2660. [PMID: 20178099 DOI: 10.1002/ijc.25273] [Cited by in Crossref: 55] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
15 Zheng Y, Wang L, Zhang JP, Yang JY, Zhao ZM, Zhang XY. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J Gastroenterol 2010; 16(3): 339-344 [PMID: 20082479 DOI: 10.3748/wjg.v16.i3.339] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
16 Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y. Premalignant lesions in gastric cancer. Clin J Gastroenterol 2010;3:6-12. [PMID: 26189899 DOI: 10.1007/s12328-009-0130-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 de Vries AC, Haringsma J, de Vries RA, ter Borg F, Nagtzaam NM, Steyerberg EW, van Dekken H, Kuipers EJ. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc 2009;70:18-25. [PMID: 19249770 DOI: 10.1016/j.gie.2008.08.041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
18 Kang KP, Lee HS, Kim N, Kang HM, Park YS, Lee DH, Choe G, Kim JS, Jung HC, Song IS. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009;24:140-8. [PMID: 18713298 DOI: 10.1111/j.1440-1746.2008.05546.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
19 Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer 2009;12:189-97. [PMID: 20047123 DOI: 10.1007/s10120-009-0527-6] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
20 Fang JY. Perplexity and prospect for diagnosis and treatment of chronic atrophic gastritis. Shijie Huaren Xiaohua Zazhi 2008; 16(10): 1027-1030 [DOI: 10.11569/wcjd.v16.i10.1027] [Reference Citation Analysis]
21 De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007;26 Suppl 2:25-35. [PMID: 18081646 DOI: 10.1111/j.1365-2036.2007.03475.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
22 de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, Kuipers EJ. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-70. [PMID: 17698860 DOI: 10.1136/gut.2007.127167] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
23 Fang JY, Liu WZ, Shi Y, Ge ZZ, Xiao SD. Consensus on chronic gastritis in China--Second National Consensus Meeting on Chronic Gastritis (14-16 September 2006 Shanghai, China). J Dig Dis 2007;8:107-19. [PMID: 17532824 DOI: 10.1111/j.1443-9573.2007.00295.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
24 de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007;12:1-15. [PMID: 17241295 DOI: 10.1111/j.1523-5378.2007.00475.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
25 Genta RM. Assessing the regression of Barrett esophagus: don't try it at home. Adv Anat Pathol 2006;13:127-30. [PMID: 16778476 DOI: 10.1097/00125480-200605000-00004] [Reference Citation Analysis]
26 Rubio CA, Jónasson J, Nesi G, Mandai K, Pisano R, King A, Owen D. Extensive intestinal metaplasia in gastric carcinoma and in other lesions requiring surgery: a study of 3,421 gastrectomy specimens from dwellers of the Atlantic and Pacific basins. J Clin Pathol 2005;58:1271-7. [PMID: 16311346 DOI: 10.1136/jcp.2005.029587] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
27 Sun JH, Das KK, Amenta PS, Yokota K, Watari J, Sato T, Kohgo Y, Das KM. Preferential expression of cyclooxygenase-2 in colonic-phenotype of gastric intestinal metaplasia: association with helicobacter pylori and gastric carcinoma. J Clin Gastroenterol 2006;40:122-8. [PMID: 16394872 DOI: 10.1097/01.mcg.0000196461.15186.0d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
28 Stolte M, Vieth M. Gastritis and gastric cancer: which morphological type of Helicobacter gastritis is a precancerous risk. Chin J Dig Dis. 2005;6:110-111. [PMID: 16045597 DOI: 10.1111/j.1443-9573.2005.00210.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Tanaka H, Tsukamoto T, Mizoshita T, Inada K, Ogasawara N, Cao X, Kato S, Joh T, Tatematsu M. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 2005;447:806-15. [PMID: 16088401 DOI: 10.1007/s00428-005-0040-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
30 Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005;115:463-469. [PMID: 15688378 DOI: 10.1002/ijc.20852] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 2.9] [Reference Citation Analysis]
31 Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am. 2005;89:313-344, viii. [PMID: 15656929 DOI: 10.1016/j.mcna.2004.09.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 5.3] [Reference Citation Analysis]
32 Kuipers EJ, Siersema PD. The aetiology and clinical relevance of gastric intestinal metaplasia. Dig Liver Dis 2004;36:501-4. [PMID: 15334768 DOI: 10.1016/j.dld.2004.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Bodger K, Campbell F, Rhodes JM. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope. J Clin Pathol 2003;56:703-8. [PMID: 12944557 DOI: 10.1136/jcp.56.9.703] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
34 Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003;36:S37-43; discussion S61-2. [PMID: 12702964 DOI: 10.1097/00004836-200305001-00007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
35 Haber MM. Histologic precursors of gastrointestinal tract malignancy. Hematology/Oncology Clinics of North America 2003;17:389-412. [DOI: 10.1016/s0889-8588(03)00019-4] [Reference Citation Analysis]
36 Haber MM. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol Clin North Am 2002;31:395-419. [PMID: 12134610 DOI: 10.1016/s0889-8553(02)00007-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
37 Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983-98. [PMID: 11866488 DOI: 10.1053/bega.2001.0253] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 3.3] [Reference Citation Analysis]
38 Kuipers EJ, Meuwissen SG. The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology 2000;118:795-8. [PMID: 10734031 DOI: 10.1016/s0016-5085(00)70149-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
39 Kuipers EJ, Meuwissen SGM. Long-term proton pump inhibitor therapy accelerates the onset of atrophic gastritis in Helicobacter pylori -positive patients. Helicobacter pylori 2000. [DOI: 10.1007/978-94-011-3927-4_28] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Greaves P. Digestive System 1. Histopathology of Preclinical Toxicity Studies 2000. [DOI: 10.1016/b978-044450514-9/50007-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
41 Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999;34:410-5. [PMID: 10231415 DOI: 10.1046/j.1365-2559.1999.00652.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.5] [Reference Citation Analysis]
42 Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999;13 Suppl 1:3-11. [PMID: 10209681 DOI: 10.1046/j.1365-2036.1999.00002.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 187] [Article Influence: 6.5] [Reference Citation Analysis]
43 Dixon MF. Atrophy, metaplasia and dysplasia - a risk for gastric cancer: are they reversible? Helicobacter pylori 1998. [DOI: 10.1007/978-94-011-4882-5_36] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
44 Akashi H, Hinoda Y, Itoh F, Adachi M, Endo T, Imai K. A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4. Int J Cancer 1997;73:795-801. [PMID: 9399654 DOI: 10.1002/(sici)1097-0215(19971210)73:6<795::aid-ijc4>3.0.co;2-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
45 Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol 1994;25:994-1005. [PMID: 7927322 DOI: 10.1016/0046-8177(94)90058-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 2.4] [Reference Citation Analysis]
46 Filipe MI, Muñoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9. [PMID: 8168991 DOI: 10.1002/ijc.2910570306] [Cited by in Crossref: 298] [Cited by in F6Publishing: 313] [Article Influence: 10.3] [Reference Citation Analysis]
47 Ohe Y, Hinoda Y, Irimura T, Imai K, Yachi A. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Jpn J Cancer Res 1994;85:400-8. [PMID: 7515385 DOI: 10.1111/j.1349-7006.1994.tb02373.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lamberts R. Einfluβ einer langfristigen Säuresuppression auf die Malignomentstehung im Magen. Ökosystem Darm VI 1994. [DOI: 10.1007/978-3-642-85187-2_27] [Reference Citation Analysis]
49 Eidt S, Stolte M. Helicobacter pylori and gastric malignancy. Zentralbl Bakteriol 1993;280:137-43. [PMID: 8280935 DOI: 10.1016/s0934-8840(11)80949-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Jass JR. Is Intestinal Metaplasia of Gastric Mucosa a Precancerous Lesion? In: Zhang Y, Kawai K, editors. Precancerous Conditions and Lesions of the Stomach. Berlin: Springer Berlin Heidelberg; 1993. pp. 49-64. [DOI: 10.1007/978-3-642-77495-9_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
51 Levine T, Price A. The precancer-cancer sequence. Helicobacter pylori Infection 1993. [DOI: 10.1007/978-94-011-2216-0_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
52 Wright PA, Quirke P, Attanoos R, Williams GT. Molecular pathology of gastric carcinoma: progress and prospects. Hum Pathol 1992;23:848-59. [PMID: 1644431 DOI: 10.1016/0046-8177(92)90394-i] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 1.4] [Reference Citation Analysis]
53 Filipe MI. Borderline Lesions of the Gastric Epithelium: New Indicators of Cancer Risk and Clinical Implications. Progress in Surgical Pathology 1992. [DOI: 10.1007/978-3-662-09515-7_12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
54 Carter RL. Histopathological Diagnosis of Early Cancer and Antecedent Lesions. Cancer Diagnosis 1992. [DOI: 10.1007/978-3-642-76899-6_17] [Reference Citation Analysis]
55 Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32:1110-3. [PMID: 1955163 DOI: 10.1136/gut.32.10.1110] [Cited by in Crossref: 164] [Cited by in F6Publishing: 189] [Article Influence: 5.1] [Reference Citation Analysis]
56 Murayama H, Kikuchi M, Enjoji M, Morita N, Haraguchi Y. Changes in gastric mucosa that antedate gastric carcinoma. Cancer 1990;66:2017-26. [PMID: 1699656 DOI: 10.1002/1097-0142(19901101)66:9<2017::aid-cncr2820660929>3.0.co;2-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
57 Xerri L, Payan MJ, Choux R, Gros N, Figarella-Branger D, Sarles H. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. Hum Pathol 1990;21:927-31. [PMID: 1697555 DOI: 10.1016/0046-8177(90)90176-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
58 Matsukuma A, Mori M, Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 1990;66:689-94. [PMID: 2386900 DOI: 10.1002/1097-0142(19900815)66:4<689::aid-cncr2820660417>3.0.co;2-f] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
59 Sipponen P. Gastric dysplasia. Curr Top Pathol 1990;81:61-76. [PMID: 2407446 DOI: 10.1007/978-3-642-74662-8_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
60 Correa P. Prospects for Early Detection of Gastric Cancer and Precancerous Lesions. New Trends in Gastric Cancer 1990. [DOI: 10.1007/978-94-009-2167-2_6] [Reference Citation Analysis]
61 Sossai P, Cielo R, Barbazza R. Is intestinal metaplasia a risk for gastric carcinoma? Postgrad Med J 1989;65:604. [PMID: 2602266 DOI: 10.1136/pgmj.65.766.604] [Reference Citation Analysis]
62 Bogomoletz WV. Apport de ľhistochimie des mucines à ľétude et au diagnostic des conditions et lésions précancéreuses de la muqueuse gastrique. Acta Endosc 1988;18:5-14. [DOI: 10.1007/bf02965010] [Reference Citation Analysis]
63 Ramesar KC, Sanders DS, Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J Clin Pathol 1987;40:1287-90. [PMID: 3693566 DOI: 10.1136/jcp.40.11.1287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 1.3] [Reference Citation Analysis]
64 Jass JR. Intestinal metaplasia and gastric cancer. Histopathology 1987;11:881. [PMID: 3623443 DOI: 10.1111/j.1365-2559.1987.tb01893.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]